Published in Blood Cells on January 01, 1990
The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect Immun (2007) 0.92
Role of cytoskeletal elements in expression of monocyte urokinase plasminogen activator receptor, activation-associated antigen Mo3. Clin Diagn Lab Immunol (1994) 0.77
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Barriers to xenotransplantation. Nat Med (1995) 2.44
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol (2000) 2.30
Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08
Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci U S A (1992) 1.95
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg (1998) 1.46
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation (2000) 1.43
Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol (1994) 1.40
Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med (1997) 1.38
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Subunit composition and specificity of the major cyst fluid antigens of Echinococcus granulosus. Mol Biochem Parasitol (1989) 1.35
Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am J Pathol (1986) 1.33
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol (2000) 1.33
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31
Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today (1997) 1.31
Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol (1993) 1.30
Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 1.25
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol (1995) 1.25
Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest (1996) 1.24
Delayed xenograft rejection. Immunol Today (1996) 1.23
Beneficial effects of targeting CCR5 in allograft recipients. Transplantation (2001) 1.22
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22
Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22
Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation (1983) 1.19
Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation (1995) 1.17
Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann N Y Acad Sci (2000) 1.17
Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17
Immunohistological studies with monoclonal antibodies. Methods Enzymol (1986) 1.16
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16
A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol (1982) 1.15
Monoclonal antibodies to identify tumour cells in CSF. Lancet (1983) 1.15
P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med (1994) 1.14
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol (1987) 1.13
Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J Immunol (1985) 1.13
Human seminal clusterin (SP-40,40). Isolation and characterization. J Clin Invest (1990) 1.12
Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev (1984) 1.12
Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen. Lab Invest (1984) 1.11
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10
Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Transplantation (1997) 1.08
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol (1997) 1.08
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol (1999) 1.08
Characterization of nonhuman primate epidermal and dermal dendritic cells with monoclonal antibodies. A study of Langerhans cells and indeterminate cells in the rhesus monkey. Lab Invest (1987) 1.07
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation (1997) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. Am J Transplant (2012) 1.06
cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol (1992) 1.06
Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation (1994) 1.05
Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts. J Immunol (1993) 1.05
Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation (2000) 1.05
Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis. Clin Nephrol (1984) 1.04
Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation (1998) 1.03
Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response. Lab Invest (1986) 1.03
Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int Immunol (1999) 1.03
Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol (2001) 1.02
Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation (1993) 1.01
Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. J Pharmacokinet Biopharm (1992) 1.01
CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation (1996) 1.01
Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J Exp Med (1993) 1.01
IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice. J Immunol (1999) 1.01
Phenotypic transformation of macrophages to Langerhans cells in the skin. Am J Pathol (1986) 1.00
Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J Neuroimmunol (2000) 1.00
Immunohistologic analysis of the cell surface antigens of human dendritic cells using monoclonal antibodies. Transplant Proc (1984) 1.00
Monoclonal antibodies to human glomerular cells: a marker for glomerular epithelial cells. Nephron (1983) 0.99
Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis. Lymphokine Cytokine Res (1992) 0.99
Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J Immunol (2000) 0.98
Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest (2004) 0.98
Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med (1997) 0.98
Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunol Rev (1993) 0.98
Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies. Am J Nephrol (1984) 0.98
CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol (1993) 0.97
Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output. Hum Reprod (2009) 0.97
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol (1997) 0.97
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation (1997) 0.96
Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol (1995) 0.96
Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation (2000) 0.96
The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodies. Pathology (1982) 0.96
Pathways of procoagulation in discordant xenografting. Transplant Proc (1994) 0.96
T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation (1996) 0.95
Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation (1994) 0.95
CD4 monoclonal antibodies in organ transplantation--a review of progress. Transplantation (1991) 0.94
Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation (1992) 0.93
Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol (1998) 0.93